A Patient-centered Intervention Using Technology to Reduce Colorectal Cancer Disparities in Primary Care
NCT ID: NCT03407417
Last Updated: 2025-05-06
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
960 participants
INTERVENTIONAL
2018-11-08
2024-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reducing Rural Colon Cancer Disparities
NCT03457454
Implementing a Multilevel Intervention to Accelerate Colorectal Cancer Screening and Follow-up
NCT04514341
Personal Electronic Health Records in Improving Screening Rates for Colorectal Cancer
NCT01032746
Personalized Screening Plans to Increase Colorectal Cancer Screening in Healthy Participants
NCT00617071
Virtual Human Delivered Nutrition Module for Colorectal Cancer Prevention
NCT04192071
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Virtual Human (VH)
Patients were randomly assigned to a virtual human (VH) screening condition after completing the eligibility for CRC requirements.
virtual technology
The app will first ask participants a short series of questions designed to assess their baseline risk for colon cancer. Highly tailored patient reminders will be customized using all 12 constructs.
Text-Base (TB)
Patients were randomly assigned to a text-based (TB) screening condition after completing the eligibility for CRC requirements.
virtual technology
The app will first ask participants a short series of questions designed to assess their baseline risk for colon cancer. Highly tailored patient reminders will be customized using all 12 constructs.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
virtual technology
The app will first ask participants a short series of questions designed to assess their baseline risk for colon cancer. Highly tailored patient reminders will be customized using all 12 constructs.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* have an email account or the ability to receive texts
* willingness to be re-contacted
* consent to MRR related to CRC screening
* not remember completing any CRC screening within recommended guidelines (i.e., \<10 years for colonoscopy, \<1 year for stool test).
* complete a FIT test:
* a) with a negative result only
* b) complete a FIT test with a positive result AND undergo a completion screening colonoscopy,
* Or c) complete a colonoscopy only.
Exclusion Criteria
* doesn't have an email account or the ability to receive texts
* unwilling to be re-contacted
* Unable to consent to MRR related to CRC screening
* have not had \<10 years for colonoscopy, or 1 year for stool test
45 Years
73 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
University of Florida
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Benjamin Lok
Role: PRINCIPAL_INVESTIGATOR
University of Florida
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Florida
Gainesville, Florida, United States
University of Florida
Jacksonville, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OCR17004
Identifier Type: OTHER
Identifier Source: secondary_id
IRB201702765 -N
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.